ArticleEuropean journal of nuclear medicine and molecular imaging2019

Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use.

Tingting He et al.PubMed ↗Publisher ↗

No numbers read from the abstract.